Zobrazeno 1 - 10
of 16
pro vyhledávání: ''
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 35:563-569
Objective: To prevent postoperative relapse after HOLRBT, we compared postoperative adjuvant therapies. Methods: One hundred fifty patients with non-muscle invasive bladder cancer (NMIBC) were meanly divided into three groups: A, B, and C. Group A pa
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 34:436-443
The Wnt/β-catenin signaling pathway is one of the highly conserved signaling pathway widely reported to play essential roles in the development of various tumors and human cancers, thus serving as a potential target for anticancer therapy. However,
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 34:355-361
Background: Kinesin Family Member 3B (KIF3B) is one of the most ubiquitously expressed KIFs, which is related to numerous physiological responses. KIF3B has also been implicated in carcino...
Autor:
Seong-Jang Kim, Samuel Chang
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 31:1-6
This study was aimed to define the predictive values of preoperative Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (F-18 FDG PET/CT) parameters and compared to define effective parameters for prediction of overall su
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 30:421-426
To assess the prognostic role of total lesion glycolysis (TLG) in patients with breast cancer liver metastases (BCLM) after sequential lobar (90)Y-radioembolization ((90)Y-RE). Seventeen patients with bilobar BCLM underwent FDG PET/CT and TLG calcula
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 26:753-757
Twenty-nine (29) patients with recurrent head and neck carcinomas underwent (125)I seed permanent implantation under ultrasonography guidance and the feasibility and efficacy of (125)I seed implantation were assessed. The postplan evaluation showed t
Autor:
Warren H. Fong, Louis A. VanderMolen, Robert O. Dillman, Khosrow Mahdavi, Neil M. Barth, Stephanie E. McClure
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 26:273-277
Interleukin-2 (IL-2) was the preferred treatment for medically fit patients with advanced kidney cancer, but recently, several targeted therapies have been approved for metastatic renal cell carcinoma. We wished to determine the long-term survival ra
Autor:
Lu Wu, Meng-Chao Wu, Shuqun Shen, Feng Shen, Yefa Yang, Jun Liang, Nai-Jian Ge, Yi Wang, Wei-Ping Zhou
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 25:657-663
Few options are available to treat patients with hepatocellular carcinoma (HCC). It was tested whether the combination of iodine-131(¹³¹I)-metuximab with chemoembolization could improve outcomes in patients with intermediate HCC. Between April 200
Autor:
Martina Reitz, J Atzpodien
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 23:129-134
The aim of this study was to evaluate the prognostic impact of pretreatment neutrophils, previously rendered statistically independent, on the response and on long-term survival of metastatic renal carcinoma patients treated with outpatient subcutane
Autor:
J Atzpodien, Martina Reitz
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 22:551-555
Twenty-four (24) pretreated patients with relapsed high-risk resected The American Joint Committee on Cancer (AJCC) stage IIA-IV melanoma received adjuvant peptide vaccinations derived from the melanosomal antigens MelanA/MART1, MAGE-1, gp100, and ty